10
Participants
Start Date
September 1, 2025
Primary Completion Date
January 31, 2028
Study Completion Date
January 31, 2030
Endoscopic Sleeve Gastroplasty (ESG) Procedure
The ESG procedure will be performed under general anesthesia monitored by an anesthesiologist. The device that will be used is called the Apollo Endosurgery ESG System, which is the only FDA approved device for the reduction of stomach volume through endoscopic sleeve gastroplasty for adult patients with obesity. This device works by being attached to a standard upper endoscope and is inserted through the mouth and goes into the stomach. When in the stomach, the back and front wall of the stomach will be stitched together to reduce the size of the stomach and help decrease the amount of food a patient can eat and drink at one time before feeling full.
Collaborators (1)
Boston Scientific Corporation
INDUSTRY
Children's Hospital of Philadelphia
OTHER